CC

Caxton Corporation Portfolio holdings

AUM $9.85M
This Quarter Return
-30.91%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$5.08M
AUM Growth
+$5.08M
Cap. Flow
-$8.85M
Cap. Flow %
-174.27%
Top 10 Hldgs %
99.52%
Holding
15
New
–
Increased
1
Reduced
1
Closed
3

Top Buys

1
GLD icon
SPDR Gold Trust
GLD
$37.2K

Top Sells

1
XERS icon
Xeris Biopharma Holdings
XERS
$6.83M
2
SPY icon
SPDR S&P 500 ETF Trust
SPY
$1.65M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
$355K
4
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$50.9K

Sector Composition

1 Healthcare 87.74%
2 Financials 4.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RZLT icon
1
Rezolute
RZLT
$619M
$3.83M 75.28% 1,318,967 – –
GLD icon
2
SPDR Gold Trust
GLD
$107B
$374K 7.36% 1,298 +129 +11% +$37.2K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.09T
$249K 4.9% 467 -666 -59% -$355K
MNMD icon
4
MindMed
MNMD
$676M
$199K 3.92% 34,073 – –
BCAX
5
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$143K 2.81% 10,941 – –
CMPX icon
6
Compass Therapeutics
CMPX
$483M
$82.6K 1.63% 43,465 – –
LXEO icon
7
Lexeo Therapeutics
LXEO
$259M
$61.9K 1.22% 17,851 – –
KYTX icon
8
Kyverna Therapeutics
KYTX
$160M
$44.4K 0.87% 22,981 – –
CRDF icon
9
Cardiff Oncology
CRDF
$140M
$41.7K 0.82% 13,287 – –
IKT icon
10
Inhibikase Therapeutics
IKT
$134M
$35.9K 0.71% 16,393 – –
ACET icon
11
Adicet Bio
ACET
$59.9M
$13.2K 0.26% 17,488 – –
CNTX icon
12
Context Therapeutics
CNTX
$75.4M
$11.3K 0.22% 18,403 – –
CBIO
13
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
– – -203,578 Closed -$50.9K
SPY icon
14
SPDR S&P 500 ETF Trust
SPY
$658B
– – -2,823 Closed -$1.65M
XERS icon
15
Xeris Biopharma Holdings
XERS
$1.26B
– – -2,015,157 Closed -$6.83M